## Abstract Schwann cells differentiate in vivo in response to contact with axons, and cAMP simulates some of these aspects of differentiation in vitro, particularly morphologic changes and expression of certain phenotypic molecules. Unfractionated inflammatory cytokines inhibit cAMP‐induced Schwan
Interferon-alpha and transforming growth factor-β co-induce growth inhibition of human tumor cells
✍ Scribed by S. Foser; I. Redwanz; M. Ebeling; C. W. Heizmann; U. Certa
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 613 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited
The effects of transforming growth factor-01 (TGF-01) on human hematopoiesis were evaluated in combination with two other regulatory cytokines, namely, recombinant human tumor necrosis factor-a! (TNF-a) and recombinant human interferon-a (rIFN-a). Combinations of TNF-a and TGF-01 resulted in a syner
Vitamin A or retinol is an important agent in the normal differentiation and growth of cells. Retinol is an effective inhibitor of the growth of many transformed cells in vitro and in vivo but its mechanism of action is unclear. Transforming growth factor alpha (TGFa) is a known mitogen. We examined
A number of cytokines and growth factors may affect astrocyte proliferation and functions. Transforming growth factor-pl (TGF-P1) is a pleiotropic cytokine which exerts multiple effects on growth and differentiation of different cell types. TGF-P1 is present in low amounts in the normal brain. TGF-P
Prolactin (PRL) is a potent mitogen in cultured astrocytes. Because one of the major effects of astrocyte proliferation is the expression of inflammatory cytokines, we examined the effect of PRL-induced mitogenesis on the expression of interleukin-1 (IL-I a), tumor necrosis factor-a (TNF-a), and tra